TQ-F3083 capsules

· Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TQ-F3083 capsules, covering 2020-03-13 to 2020-03-13. Get the full timeline:

Most recent: Clinical Trial Update: Study of TQ-F3083 Capsules in Subjects With Type 2 Diabetes Mellitus [Phase 2]